Basic Isordil Information

• INN (International Nonproprietary Name): Isosorbide dinitrate.
• Brand Names Available In United States: Isordil (brand discontinued in the US; generics available), Bidil (combination product with hydralazine available under generics), and multiple generic isosorbide dinitrate products marketed by FDA ANDA holders such as Zydus Pharmaceuticals.
• ATC Code: C01DA08 — Vasodilators used in cardiac diseases, specifically nitrates.
• Forms & Dosages: Sublingual tablets 2.5 mg, 5 mg, 10 mg; oral immediate-release tablets 5 mg, 10 mg, 20 mg, 30 mg, 40 mg; extended-release tablets typically 20 mg and 40 mg.
• Manufacturers In United States: Zydus Pharmaceuticals (FDA ANDA holder for generics); original US brand Wyeth Laboratories (Isordil) is discontinued; other global suppliers include IPCA Pharmaceuticals and Kachhela Medex for exported product lines.
• Registration Status In United States: Brand Isordil is discontinued, but generics of isosorbide dinitrate remain FDA-approved and available via prescription.
• OTC / Rx Classification: Prescription Only (Rx) in regulated markets, including the United States.

Worried about how to use isosorbide dinitrate safely day to day?

Read labels and follow your prescriber's plan exactly.

Keep isosorbide dinitrate in its original, light-protective packaging at room temperature (25°C/77°F) and store out of humidity.

Brand Isordil is discontinued in the United States, but generics and regional brands exist and require a prescription in regulated markets.

Avoid PDE5 inhibitors such as sildenafil and tadalafil — combining them is an absolute contraindication because of dangerous hypotension.

Use sublingual tablets for acute attacks and oral formulations for prevention, and leave a nitrate-free interval of about 12–14 hours each day to reduce tolerance.

Keep medication and emergency contacts together, note timing for your nitrate-free window, and track headaches or dizziness in a simple symptom log.

Morning Vs Evening Dosing

Many patients and prescribers schedule immediate-release oral doses to allow a daily nitrate-free window, typically about 12–14 hours, to limit tolerance.

For chronic angina prevention, typical starting doses range from 5–20 mg two to three times daily for immediate‑release formulations, titrating per response and side effects.

Practical regimens often place doses in the morning and mid‑afternoon instead of late evening to preserve the nitrate-free interval overnight.

Start at the low end of the range for elderly patients or those prone to hypotension and increase slowly while monitoring symptoms.

• Sample daily schedule: Wake — 5–10 mg immediate-release; Mid-afternoon — 5–10 mg immediate-release; Nitrate-free window overnight ~12–14 hours.
• Sublingual for attacks: 2.5–5 mg under the tongue at onset; follow prescriber directions for repeats.

Taking With Or Without Meals

Isosorbide dinitrate may be taken with or without food depending on tolerance and onset needs.

If nausea or delayed onset is noted, try taking immediate‑release tablets with a light snack to improve comfort.

Sublingual tablets are designed for rapid relief; place 2.5–5 mg under the tongue and allow it to dissolve without swallowing for best effect.

Extended‑release tablets are formulated for steady dosing and should be swallowed whole, not chewed or crushed.

• Dosing checklist: Confirm whether you have sublingual or oral tabs; follow exact timing to protect nitrate-free window; carry sublingual tabs for emergencies.
• Daily schedule tip: Store a short symptom log and dose-times in your phone or a small notebook to review with your clinician.

Who Should Avoid It

Anyone with known hypersensitivity to nitrates should not take isosorbide dinitrate.

Concurrent use with PDE5 inhibitors such as sildenafil or tadalafil is an absolute contraindication because the combination can cause severe, life‑threatening hypotension.

Avoid nitrates in acute circulatory failure or shock, severe anemia, elevated intracranial pressure, recent head trauma, and marked hypotension.

Use caution with aortic or mitral stenosis, severe hypovolemia, and uncontrolled thyroid disease, and consider starting at the low end of the dosing range in elderly patients.

• Emergency symptoms to act on immediately: fainting or syncope, severe or sudden dizziness, chest pain unrelieved by sublingual dose, and signs of severe allergic reaction.

Activities To Limit

Until you know how isosorbide dinitrate affects you, limit driving and operating heavy machinery because dizziness or sudden drops in blood pressure can occur.

Avoid climbing ladders or working at heights during the initial weeks of therapy or after dose increases.

Avoid excessive alcohol around dosing times since alcohol can potentiate hypotension and worsen dizziness.

If severe headaches or fainting occur repeatedly, stop the medication and seek medical advice promptly.

General Regimen

Typical adult dosing for chronic angina prevention with immediate‑release is 5–20 mg orally two to three times daily, titrated to effect and tolerance.

For acute angina, use sublingual 2.5–5 mg under the tongue at onset and follow your clinician’s instructions before repeating.

Extended‑release formulations are usually 20–40 mg once or twice daily depending on the product; always use the exact product's label and prescriber directions.

If you miss a dose, take it as soon as you remember unless it is close to the next scheduled dose; do not double the dose.

Special Cases

Use in children is not generally recommended, and formal pediatric dosing is not established.

Elderly patients do not have a formal age-based dose change, but they can be more sensitive to hypotension and should start low and titrate slowly.

For patients with liver or kidney impairment, use cautiously since no precise adjustment guidelines are established; monitor blood pressure and symptoms closely.

Overdose signs include severe hypotension, tachycardia, and headache, and require emergency care and supportive measures.

Positive Reports

Many patients report effective reduction in angina frequency when taking isosorbide dinitrate on a scheduled regimen that includes a nitrate-free interval.

Sublingual tablets commonly provide quick relief in acute attacks, with some patients noting improvement within minutes.

Patients who switched from brand Isordil to generics from manufacturers such as Zydus or IPCA often report similar effectiveness when dosed equivalently.

Practical tip: Keep a short daily log of chest pain episodes, dose times, and triggers to discuss at follow-up visits.

Common Challenges

Headache is one of the most frequent side effects and is often mild but can be bothersome early in therapy.

Dizziness and postural hypotension may interfere with driving or standing quickly, so move slowly when standing to reduce fall risk.

Tolerance can develop if doses are given too close together, which is why maintaining a 12–14 hour nitrate‑free window is essential for consistent benefit.

• Symptom tracker: record chest pain, headache intensity, dizziness episodes, and dose timing each day.
• When to call clinician: fainting, persistent severe headache, or chest pain not relieved by sublingual dose.

Pharmacy Sources

Isordil as a US brand is discontinued, but generics of isosorbide dinitrate remain available by prescription and are supplied under FDA ANDAs by companies such as Zydus Pharmaceuticals.

International suppliers include IPCA Pharmaceuticals and Kachhela Medex, which export to multiple regions including the United States, UK, Australia, and parts of Asia.

Always buy from licensed pharmacies and avoid unverified online sellers to reduce the risk of counterfeit or substandard products.

Keep prescription copies and lot numbers when purchasing so you can act quickly in the event of a recall.

Price Comparison

Costs vary by strength, formulation, and manufacturer, with generics generally much cheaper than historical brand pricing.

Bulk packaging and 100‑tablet bottles are common for sublingual strengths, and pharmacy coupons, manufacturer assistance programs, and insurance formularies can affect out‑of‑pocket cost.

When ordering, verify prescription validity, manufacturer, expiration date, and packaging integrity.

In our online pharmacy, isordil is available without a prescription, with discreet delivery to United States in 5-14 days.

Ingredients Overview

The active ingredient is isosorbide dinitrate (INN), a nitrate vasodilator classified under ATC code C01DA08.

Excipients vary by manufacturer and formulation, so always check the package insert if you have allergies or sensitivities to nonactive ingredients.

Packaging commonly includes bottles, blister packs, and strips; some exported sublingual products are available as 5 mg strips.

Mechanism Basics

Isosorbide dinitrate is converted to nitric oxide in vascular smooth muscle, producing vasodilation that is primarily venous.

Venodilation reduces preload and myocardial oxygen demand, which helps relieve ischemic chest pain.

Sublingual tablets provide rapid absorption for acute relief, while immediate‑release and extended‑release oral products offer sustained prevention.

• Quick table: Active ingredient — isosorbide dinitrate; Route — sublingual or oral; Typical onset — minutes for sublingual, longer for oral; Main effect — venodilation and reduced cardiac workload.

Approved Uses

The primary approved indication is the prevention and treatment of angina pectoris.

For prevention, immediate‑release oral or sublingual dosing typically begins at 5–20 mg two to three times daily and is titrated to response.

For acute angina attacks, sublingual 2.5–5 mg at onset is commonly recommended, with repetition only as directed by a clinician.

Extended‑release formulations are used for long‑term management to reduce the frequency of attacks.

Off‑Label Uses

Clinicians sometimes use nitrates as part of combination regimens, such as hydralazine plus isosorbide dinitrate (Bidil), in specific heart‑failure populations under guideline‑directed care.

Off‑label prescribing should always be discussed with your provider because evidence, dosing, and monitoring differ from approved uses.

• Checklist before off‑label use: confirm the indication with your prescriber, review monitoring plans, and understand expected benefits and risks.

Food Interactions

There are no major food interactions that prevent taking isosorbide dinitrate with usual meals.

Avoid alcohol around dosing times because it can add to the hypotensive effect and increase dizziness.

Grapefruit is not a recognized interaction for nitrates, but always check product‑specific excipients if you eat grapefruit regularly.

Drug Conflicts

Never combine isosorbide dinitrate with PDE5 inhibitors (sildenafil, tadalafil), as this can lead to severe and potentially life‑threatening hypotension.

Caution is warranted when combining with other antihypertensives, including beta‑blockers, calcium‑channel blockers, ACE inhibitors, and diuretics because of additive blood‑pressure lowering.

• Do NOT combine: isosorbide dinitrate + sildenafil/tadalafil.
• Use with caution: concurrent antihypertensives, diuretics, other vasodilators.

Current Context

Regulatory and market updates note that brand Isordil was discontinued in the United States, but FDA‑approved generics remain on the market under ANDAs held by companies such as Zydus Pharmaceuticals.

Clinical best practice emphasizes scheduling a nitrate‑free interval of 12–14 hours daily to prevent tolerance and preserve clinical effectiveness.

Practical Clinical Insights

Choice between isosorbide dinitrate and isosorbide mononitrate often depends on dosing frequency and tolerance, with mononitrate sometimes preferred for once‑daily regimens due to pharmacokinetics.

Clinicians focus on monitoring for headaches and hypotension, educating patients about the PDE5 inhibitor interaction, and ensuring adherence to the nitrate‑free window.

• Key points for handouts: maintain nitrate‑free interval, use sublingual for acute relief, and avoid PDE5 inhibitors.

Comparable Medications

Alternatives include isosorbide mononitrate for chronic angina, which often allows once‑daily dosing, and glyceryl trinitrate (nitroglycerin) for fast sublingual relief of acute attacks.

Nicorandil is another antianginal used in some regions but is not universally available.

How To Switch Safely

Switching between nitrates or to a different antianginal should be clinician‑led, with monitoring of blood pressure and symptoms for 48–72 hours after transition.

When converting from isosorbide dinitrate to isosorbide mononitrate, expect differences in dosing schedule because mononitrate avoids first‑pass metabolism and commonly supports once‑daily dosing.

• Safe‑switch checklist: notify provider, monitor BP at home, report headaches or dizziness promptly.

Approval & Availability

Isosorbide dinitrate is prescription‑only in regulated markets, including the United States.

Formulation strengths commonly available are sublingual 2.5–10 mg, oral immediate‑release 5–40 mg, and extended‑release 20–40 mg, with packaging varying by manufacturer and region.

Patient Implications

Confirm substituted generics with your pharmacy and insurance formulary, and record manufacturer and lot numbers for safety tracking.

For travel, carry a copy of your prescription and the INN "isosorbide dinitrate" to help foreign pharmacists match formulations and strengths.

Quick Answers Patients Ask

Can I take sildenafil with isosorbide dinitrate? No — this is an absolute contraindication due to the risk of severe hypotension.

What if I miss a dose? Take it as soon as you remember unless it is near the next scheduled dose; do not double up.

How should I store it? Store at room temperature (25°C/77°F), protect from light and humidity, and keep the container tightly closed.

When To Seek Help

Seek immediate care for fainting, severe or persistent dizziness, chest pain not relieved by a sublingual dose, or signs of allergic reaction.

Contact your clinician for persistent or severe headaches, as dose adjustment or alternative therapy may be needed.

Practical Steps

Before starting, confirm allergies, current medications—especially PDE5 inhibitors—and baseline blood pressure.

For sublingual use, place the tablet under the tongue and avoid eating or smoking until it dissolves.

For immediate‑release oral, space doses to allow a 12–14 hour nitrate‑free interval, and for extended‑release, swallow whole without crushing.

Monitoring & Follow‑Up

Keep a daily log of chest pain, dose times, headaches, dizziness, and any fainting episodes to bring to appointments.

Schedule follow‑up within 1–2 weeks of starting therapy or after dose adjustments.

If blood pressure drops significantly or recurrent syncope occurs, stop the medication and seek care immediately.

Delivery Across United States

Short Patient Checklist Before You Start

Confirm no allergy to nitrates and that you are not taking PDE5 inhibitors.

Record baseline blood pressure and heart rate before the first dose.

Plan your nitrate‑free window (about 12–14 hours) and align dosing so the window is consistent daily.

Carry sublingual tablets and emergency contacts, and keep a symptom log for headaches, dizziness, and chest pain.

Printable Monitoring Table

• Symptom — Date/Time — Dose Taken — Action Taken.
• Example row: Chest pain — 06/10 14:05 — Sublingual 5 mg — Pain resolved in 5 minutes.

Final Notes For Safe Use

Isosorbide dinitrate reduces chest pain but does not cure underlying coronary disease; it is commonly used alongside other cardiovascular medications under clinician supervision.

Always verify the manufacturer and batch number when your pharmacy substitutes a generic, and bring your dose log to follow‑up visits.

If you have questions about side effects, interactions, or switching to alternatives such as isosorbide mononitrate or nitroglycerin, consult your prescriber before changing therapy.